1Lunven C,Gauffeny C,Lecoffre C,et al.Inhibition by Argatroban,a specific thrombin inhibitor,of platelet activation by fibrin clot-associated thrombin.Thromb Haemost,1996,75(1):154-160.
2Mureebe L,Turnquist SE,Silver D.Inhibition of intimal hyperplasia by direct thrombin inhibitors in an animal vein bypass model.Ann Vasc Surg,2004,18(2):147-150.
3Keating FK,Dauerman HL,Whitaker DA,et al.Increased expression of platelet P-selectin and formation of platelet-leukocyte aggregates in blood from patients treated with unfractionated heparin plus eptifibatide compared with bivalirudin.Thromb Res,2006,118(3):361-369.
4Farivar AS,Delgado MF,McCourtie AS,et al.Crosstalk between thrombosis and inflammation in lung reperfusion injury.Ann Thorac Surg,2006,81(3):1061-1067.
5Bea F,Kreuzer J,Preusch M,et al.Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein Edeficient mice.Arterioscler Thromb Vasc Biol,2006,26(12):2787-2792.
6Mirabet M,Garcia-Dorado D,Ruiz-Meana M,et al.Thrombin increases cardiomyocyte acute cell death after ischemia and reperfusion.J Mol Cell Cardiol,2005,39(2):277-283.
7Ueki Y,Matsumoto K,Kizaki Y,et al.Argatroban increases nitric oxide levels in patients with peripheral arterial obstructive disease:placebocontrolled study.J Thromb Thrombolysis,1999,8(2):131-137.
10Lewis BE,Matthai WH Jr,Cohen M,et al.Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.Catheter Cardiovasc Interv,2002,57(2):177-184.
二级参考文献10
1[3]LaMONTE MP.Argatroban in thrombotic stroke[J].Pathophysiol Haemost Thromb,2002,32(Suppl 3):39-45.
2[4]LEWIS BE,MATTHAI WH,COHEN M,et al.ARG-216/310/311 Study Investigators.Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia[J].Catheter Cardiovasc Interv,2002,57:177-184.
3Okamoto S,Hijikata A,Kinojo K,et al.A novel series of synthetic thrombin-inhibitors having extremely potent and highly selective action.Kobe J Med Sci,1975,21:43-51
4Bauer M,Brandstetter H,Turk D,et al.Crystallographic determination of thrombin complexes with small synthetic inhibitors as a starting point for the receptor-based design of antithrombotics.Semin Thromb Hemost,1993,19:352-360
5Okamoto S,Hijikata A,Kikumoto R,et al.Potent inhibition of thrombin by the newly synthesized arginine derivative No.805 The importance of sterostructure of its hydrophobic carboxamide portion.Biochem Biophys Res Commun,1981,101:440-446
6Kumada T,Abiko Y.Comparative study on heparin and a synthetic thrombin inhibitor Ⅲ-deficient animals.Thromb Res,1981,24:285-298
7Hantgan RR,Jerome WG,Hursting M J,et al.No effect of clot age or thrombolysis on argatroban's inhibition of thrombin.Blood,1998,92:2064-2074
8Kobayashi S,Tazaki Y.Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis.Semin Thromb Haemost,1997,23:531-534
9Jeanine M.An overview of the direct thrombin inhibitor argatroban.Pathophysiol Haemost Thromb,2002,32:9-14
